"Timely diagnosis of thyroid disorders is pivotal, given the challenges posed by symptom similarities with other conditions. The integration of advanced reagents in thyroid function tests, including ultrasensitive TSH and Free T3/T4 assessments, significantly enhances sensitivity and specificity. TPO antibody testing further contributes to the accurate differentiation of autoimmune disorders. In-vitro diagnostics (IVD) emerges as a key player in the timely detection of thyroid disorders, providing nuanced insights into thyroid function for more effective management."
Dr. Varsha Vadera
Consultant & Head – Laboratory Medicine & Advanced Diagnostics Kokilaben Dhirubhai Ambani Hospital Mumbai
"The laboratory ensures timely and accurate HIV testing through meticulous methodologies, utilizing high-quality reagents for early detection of HIV antibodies and antigens. Protocols prioritize verification, internal quality controls, and distinctive markers for urgent testing. Quality control measures, guided by NACO guidelines, involve immunochromatographic methods and viral load testing to confirm results and minimize false negatives/positives. Continuous staff training aligns with ISO15189 and ensures proficiency in the latest testing methodologies, contributing to comprehensive and accurate diagnostics across various infections, including HIV, HBV, and HCV."
Prof. Dr. CN Srinivas
Vice President Technical, Head of HLA and Transplantation Immunology Head of Laboratory Services Agilus Diagnostics Central Reference Laboratory Chennai
"Laboratories ensure accurate and timely HIV testing by simplifying procedures following NACO guidelines, reducing equipment needs. Protocols prioritize high-risk cases, utilizing different testing schemes and combining antigen and antibody tests for efficiency. Stringent quality control measures and staff training minimize false results. Laboratories stay updated with advancements, employing fourth-generation testing, viral load assessments, and bioinformatics. Continuous training adheres to ISO: 15189 2022 standards, marking a significant evolution from past stigmatized perceptions of HIV testing."
Dr. Anusha Rohit
Head – Department of Microbiology Madras Medical Mission, Chennai
"Clinical chemistry analyzers play a crucial role in the early detection of cardiovascular risk biomarkers, thus facilitating proactive measures for preventing heart-related complications. Providing clinicians with accurate and precise test reports is important in contributing to diagnosis and ultimately to positive patient outcomes. Also, ongoing medical education ensures that the laboratory consultants stay updated on recent advancements, thus improving diagnostic accuracy."
Dr. Anjali Manocha
Vice Chairperson & Sr. Consultant Department of Biochemistry Sir Ganga Ram Hospital, New Delhi
"Early cancer detection is vital for favorable outcomes, and In-vitro diagnostics (IVD) is instrumental in this pursuit by offering precise tools for biomarker analysis. Pathologists, however, grapple with challenges like discerning aggressive lesions. With advancements in IVD, particularly molecular diagnostics, these challenges are being addressed, enhancing diagnostic accuracy. Use of proteomics, molecular testing, engineered biosensors, nanoparticles, activity-based diagnostics, and use of AI are helping in tumor detection via amplified, activity-based readouts."
Dr. Sohini Sengupta
Medical Laboratory Director Redcliffe Labs, Delhi, India
"Timely diagnosis is critical for managing thyroid disorders, with routine testing being essential for early detection, considering the potential lack of noticeable symptoms. Pathologists dispel common myths, clarifying that not all thyroid nodules indicate cancer, and recent advancements have made thyroid diagnostics cost-effective. Integration of advanced reagents for screening thyroid disorders enhances sensitivity and specificity, crucial for precise thyroid function tests and informed clinical decisions. Continuous medical education for pathologists is vital, providing insights into the latest developments and ensuring expertise in diagnosing and managing thyroid disorders."
"Little things matter and every little care can make a significant difference. The little mosquito bite, when ignored, can matter a lot. Effective management of malaria hinges upon timely detection. Rapid diagnostic tests are pivotal to detect malaria infections at the point of care for prompt initiation of treatment and contribute to effective disease surveillance and control efforts, ultimately saving lives and reducing transmission. Be aware & Take Care, Every Little Precaution Counts!"
Dr Ravi Gaur
Founder & Director - UNIDRG Specialty Labs (LLP), New Delhi Chairman - Medical Advisory Committee, Unipath Spl Labs, Ahmedabad India
"Early diagnosis for thrombotic conditions allows for timely intervention and management, reducing the risk of complications associated with these disorders. D-dimer is a product of blood clot breakdown. Elevated D-dimer levels suggest ongoing or recent clot formation and breakdown. It's used to detect abnormal clotting, crucial in conditions like DVT and PE. D-dimer testing is often used in conjunction with other clinical findings and imaging studies for a comprehensive diagnosis."
Dr. Mamta Soni
Sr. Consultant & HOD, Department of Haematology & Clinical Pathology Apollo Main Hospital, Chennai
"Timely cancer diagnosis is crucial for better outcomes and is a vital public health strategy globally. In-vitro diagnostics (IVD) plays a pivotal role in early detection by providing precise molecular insights through technologies like flow cytometry, next-generation sequencing (NGS), polymerase chain reaction (PCR), and immunohistochemistry (IHC). The evolving landscape of IVD holds promise for even more advanced techniques, ensuring early detection remains a cornerstone in the fight against cancer. Embracing these innovations enhances our ability to diagnose and treat cancer at its earliest stages, ultimately advancing patient care."
Dr. Kunal Sehgal
Hematopathologist and Flow Cytometrist Director, Sehgal Path Lab
"Emerging trends in pathology are pivotal in revolutionizing early detection and monitoring of kidney diseases, accentuating the significance of urinalysis analyzers and serum biomarkers. Alongside liquid biopsies and AI-driven diagnostics, these analyzers and biomarkers play a crucial role. They offer non-invasive yet precise methods for assessing renal health, providing valuable insights into kidney function and disease progression. Integrating these technologies with advanced pathology approaches enhances our ability to detect abnormalities early, tailor treatment strategies, and ultimately improve outcomes for patients with kidney disorders."
Dr. Deepa Dave
National Director – Operations Pathkind Diagnostics Delhi, India